Gabapentin Capsule
Product Images NDC 80425-0182

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0182). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Fig 1)

A line graph showing the mean pain score over an 8-week period comparing a placebo group to a Gabapentin group at 3600 mg/day. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend over time, while placebo remains relatively constant.*

FDA Label Image

Fig 2 (Fig 2)

A line graph showing mean pain scores over a 7-week period with a 3-week dose titration phase followed by a 4-week fixed dose period. The graph compares placebo and Gabapentin at 1800 mg/day and 2400 mg/day dosages, illustrating changes in pain scores across baseline to week 7.*

FDA Label Image

Fig 3 (Fig 3)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders in two studies. Study 1 shows 12% for placebo (PBO) and 29% for GBP 3600 with statistical significance indicated. Study 2 shows 14% for placebo, 32% for GBP 1800, and 34% for GBP 2400, with higher responses for gabapentin doses also statistically significant.*

FDA Label Image

Fig 4 (Fig 4)

A scatter plot comparing the percentage difference against daily dose in mg for Gabapentin in three studies labeled a, b, and c. The x-axis shows daily doses of 600, 900, 1200, and 1800 mg, while the y-axis presents percentage differences ranging from 2% to 22%. Each study is represented by different colored squares with study a in black, study b in gray, and study c in white.*

FDA Label Image

Formula (Formula)

A formula depicting the calculation for creatinine clearance (CLCr), involving variables such as age in years, weight in kilograms, serum creatinine concentration in mg/dL, and a correction factor for female patients.*

FDA Label Image

Gabapentin #30 (Gabapentin 300mg Cap Qty 30 Ndc 80425 0182)

The label for Gabapentin 300 mg capsules, bottle of 30, from Advanced Rx of Tennessee, LLC, Nashville TN. It includes the NDC number 80425-0182-01, lot number 30GAB3001221, and expiration date 5/31/2024. The label advises storage at room temperature (20°-25°C). It also shows a caution about federal law restricting drug transfer to persons other than the prescribed patient.*

FDA Label Image

Gabapentin#60 (Gabapentin 300mg Cap Qty 60 Ndc 80425 0182)

Gabapentin 300 mg capsule label from Advanced Rx of Tennessee, LLC, featuring a 60-count package. The label includes NDC 80425-0182-02, lot number 60GAB3001221 with expiration 5/31/2024, and storage instructions at 20° - 25°C (68° - 77°F). The label also states it is comparable to Neurontin.*

FDA Label Image

Gabapentin #90 (Gabapentin 300mg Cap Qty 90 Ndc 80425 0182)

The label displays Gabapentin 300 mg capsules with a quantity of 90 capsules. It is labeled by Advanced Rx of Tennessee, LLC. The label includes storage instructions, a barcode with serial number, lot number, expiration date (5/31/2024), and comparison note to Neurontin. The label indicates the product is an oral human prescription drug.*

FDA Label Image

Structure (Structure)

Chemical structure of gabapentin, depicted as a hexagonal ring with attached amino (CH2NH2) and carboxyl (CH2CO2H) functional groups, representing its molecular framework.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.